Mizuho Securities’s Takeda Pharmaceutical TAK Stock Holding History

Mizuho Securities’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-66,179	Closed	-$948K	–	218
2022 Q1	$948K	Hold	66,179	–	–	0.21%	25
2021 Q4	$902K	Hold	66,179	–	–	0.32%	13
2021 Q3	$1.08M	Buy	66,179 +2,806	+4%	+$47.1K	0.31%	19
2021 Q2	$1.07M	Sell	63,373 -75,172	-54%	-$1.28M	0.2%	25
2021 Q1	$2.53M	Buy	+138,545	New	+$2.49M	0.52%	5
2020 Q4	–	Sell	-216,270	Closed	-$3.86M	–	182
2020 Q3	$3.86M	Buy	216,270 +182,370	+538%	+$3.32M	0.69%	7
2020 Q2	$515K	Buy	+33,900	New	+$609K	0.14%	27

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mizuho Securities's TAK Position: Q2 2022 in Review

Mizuho Securities sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 66,179 shares — an estimated $948K sold.

Mizuho Securities first reported a position in TAK in Q2 2020 and held it in 7 quarters. The position peaked at $3.86M in Q3 2020. 282 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Mizuho Securities reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Mizuho Securities sold 66,179 Takeda Pharmaceutical shares in Q2 2022, an estimated $948K.
Mizuho Securities first reported a position in Takeda Pharmaceutical in Q2 2020 and held it in 7 quarters.
Mizuho Securities's Takeda Pharmaceutical position peaked at $3.86M in Q3 2020.
282 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Mizuho Securities's 13F filing for Q2 2022, filed 21 Jul 2022.